Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Reiter

Showing results (41-50 of 211) with videos related to

Pageof 22
Sort By:
Seminars in Immunopathology|May 30, 2021
Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexityPeter Valent, Lina Degenfeld-Schonburg, Irina Sadovnik, et al.
Haematologica|January 13, 2010
A polymorphism associated with STAT3 expression and response of chronic myeloid leukemia to interferon αSebastian Kreil, Katherine Waghorn, Thomas Ernst, et al.
Blood|April 26, 2007
Heterogeneous prognostic impact of derivative chromosome 9 deletions in chronic myelogenous leukemiaSebastian Kreil, Markus Pfirrmann, Claudia Haferlach, et al.
Genes, Chromosomes & Cancer|November 14, 2008
Identification of a MYO18A-PDGFRB fusion gene in an eosinophilia-associated atypical myeloproliferative neoplasm with a t(5;17)(q33-34;q11.2)Christoph Walz, Claudia Haferlach, Annette Hänel, et al.
Annals of Hematology|November 6, 2019
Magnetic resonance imaging reveals distinct bone marrow patterns in indolent and advanced systemic mastocytosisPhilipp Riffel, Mohamad Jawhar, Kristina Gawlik, et al.
Molecular Carcinogenesis|November 7, 2019
LCP1 triggers mTORC2/AKT activity and is pharmacologically targeted by enzastaurin in hypereosinophiliaGuangxin Ma, Deniz Gezer, Oliver Herrmann, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 13, 2009
Recurrent numerical aberrations of JAK2 and deregulation of the JAK2-STAT cascade in lymphomasCecile Meier, Sylvia Hoeller, Caroline Bourgau, et al.
Blood|October 5, 2006
Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosisNicolaus Kröger, Anita Badbaran, Ernst Holler, et al.
Haematologica|August 10, 2012
Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangementsAndrew Chase, Catherine Bryant, Joannah Score, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 14, 2021
Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension StudyGerald J Gleich, Florence Roufosse, Geoffrey Chupp, et al.
Pageof 22

Showing results (41-50 of 211) with videos related to

Sort By:
Pageof 22
Seminars in Immunopathology|May 30, 2021
Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexityPeter Valent, Lina Degenfeld-Schonburg, Irina Sadovnik, et al.
Haematologica|January 13, 2010
A polymorphism associated with STAT3 expression and response of chronic myeloid leukemia to interferon αSebastian Kreil, Katherine Waghorn, Thomas Ernst, et al.
Blood|April 26, 2007
Heterogeneous prognostic impact of derivative chromosome 9 deletions in chronic myelogenous leukemiaSebastian Kreil, Markus Pfirrmann, Claudia Haferlach, et al.
Genes, Chromosomes & Cancer|November 14, 2008
Identification of a MYO18A-PDGFRB fusion gene in an eosinophilia-associated atypical myeloproliferative neoplasm with a t(5;17)(q33-34;q11.2)Christoph Walz, Claudia Haferlach, Annette Hänel, et al.
Annals of Hematology|November 6, 2019
Magnetic resonance imaging reveals distinct bone marrow patterns in indolent and advanced systemic mastocytosisPhilipp Riffel, Mohamad Jawhar, Kristina Gawlik, et al.
Molecular Carcinogenesis|November 7, 2019
LCP1 triggers mTORC2/AKT activity and is pharmacologically targeted by enzastaurin in hypereosinophiliaGuangxin Ma, Deniz Gezer, Oliver Herrmann, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 13, 2009
Recurrent numerical aberrations of JAK2 and deregulation of the JAK2-STAT cascade in lymphomasCecile Meier, Sylvia Hoeller, Caroline Bourgau, et al.
Blood|October 5, 2006
Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosisNicolaus Kröger, Anita Badbaran, Ernst Holler, et al.
Haematologica|August 10, 2012
Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangementsAndrew Chase, Catherine Bryant, Joannah Score, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 14, 2021
Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension StudyGerald J Gleich, Florence Roufosse, Geoffrey Chupp, et al.
Pageof 22